Precision Medicine

New Genomics Lab Will Leverage AI to Advance Precision Medicine

by Jessica Kent

Hackensack Meridian Health (HMH) and Genomic Testing Cooperative (GTC) are launching a next generation sequencing reference laboratory that will use artificial intelligence to advance precision...

How Precision Medicine, Genomics Research is Decoding COVID-19

by Jessica Kent

Since COVID-19 has entered and spread across the US, healthcare researchers have aimed to learn everything they can about the virus. For more coronavirus updates, visit our resource page, updated...

Team Uncovers Genetic Variants that Impact COVID-19 Susceptibility

by Jessica Kent

Genetic variants may play a role in a person’s susceptibility to COVID-19, leading to a better understanding of which populations are most at risk of severe complications from the virus,...

Gene Variants May Advance Cancer Precision Medicine for Black Men

by Jessica Kent

Newly identified gene variants could possibly lead to precision medicine prostate cancer therapies specifically for black men. Black men in the US are known to disproportionately suffer from prostate...

Precision Medicine Projects to Accelerate COVID-19 Treatment

by Jessica Kent

The San Antonio Partnership for Precision Therapeutics (SAPPT) has announced the funding of three projects that will accelerate treatments for COVID-19 using precision medicine principles. For more...

Genome Mapping Method Could Accelerate Precision Medicine for Lupus

by Jessica Kent

Researchers from Children’s Hospital of Pennsylvania (CHOP) leveraged a new genome mapping approach to pinpoint two new possible therapeutic targets for lupus, while also accurately identifying...

Genome Analytics Tool Could Advance Cancer Precision Medicine

by Jessica Kent

A team from St. Jude’s Children’s Research Hospital have created a genome analytics tool to detect alterations that drive tumor formations, which could help advance cancer precision...

Johns Hopkins Leverages Microsoft AI for Precision Medicine

by Jessica Kent

Johns Hopkins Medicine (JHM) and Microsoft Azure have announced a partnership to leverage Microsoft’s artificial intelligence and analytics tools for accelerated precision medicine...

“All of Us” Precision Medicine Program to Collect COVID-19 Data

by Jessica Kent

The All of Us precision medicine research program announced that it will evaluate the spread and effects of COVID-19 through antibody testing, a survey about the pandemic’s impact, and EHR...

Predictive Analytics Model Forecasts COVID-19 Risk, Outcomes

by Jessica Kent

Cleveland Clinic researchers have developed a predictive analytics model to determine an individual patient’s likelihood of testing positive for COVID-19, as well as their potential outcomes from...

Social Determinants Data Linked to Higher Risk of Alzheimer’s

by Jessica Kent

After evaluating social determinants data and brain bank samples, researchers have found that people who live in the most disadvantaged US neighborhoods may have a higher risk of developing...

Patient Access, Privacy Vital for Integrating Genomic Data in the EHR

by Jessica Kent

Patient access, privacy, and protection are critical in facilitating the integration of genomic data into patient care and the EHR, according to a report from the American College of Medical Genetics...

“All of Us” Opens Precision Medicine Data Platform for Beta Testing

by Jessica Kent

The All of Us precision medicine research program has opened its data platform for beta testing, allowing investigators to offer feedback on its preliminary resources. The All of Us Researcher...

Big Data Analytics Tool Could Help Guide Cancer Precision Medicine

by Jessica Kent

A big data analytics tool that uses information from multiple cancer types could help researchers identify potential treatments and accelerate precision medicine, a study published in the Journal of...

Precision Medicine Informs Cost-Effective Heart Disease Treatments

by Jessica Kent

Using precision medicine approaches to tailor heart disease therapies could lead to more cost-effective treatments and improved patient outcomes, according to a study led by researchers at the...

Genomic Data Collaboration to Aid Precision Medicine, Drug Discovery

by Jessica Kent

The Colorado Center for Personalized Medicine (CCPM) at the University of Colorado Anschutz Medical Campus is partnering with the Regeneron Genetics Center (RGC) to advance precision medicine and drug...

Gene Linked to Cholesterol Regulation Could Boost Precision Medicine

by Jessica Kent

A team from the University of Wisconsin-Madison has uncovered a gene involved in regulating the body’s cholesterol, which could help advance precision medicine treatments for heart disease and...

Researchers Identify New Risk Factor for Alzheimer’s Disease, ALS

by Jessica Kent

Researchers at the HudsonAlpha Institute for Biotechnology, the University of California, San Francisco (UCSF), and the University of Alabama at Birmingham (UAB) have uncovered a new genetic risk...

Whole Genome Sequencing Reveals Genetic Risks of Schizophrenia

by Jessica Kent

In the largest-ever whole genome sequencing study of schizophrenia, researchers discovered that rare structural genetic variants could play a role in the development of the disorder. The findings...

ONC Projects Aim to Standardize SDOH Data for Precision Medicine

by Jessica Kent

The Office of the National Coordinator (ONC) is working to standardize the collection of social determinants of health data to help advance precision medicine and inform new treatments. Information...